Shovon Ashraf, Ph.D., is an associate in Goodwin's Technology Companies and Life Sciences groups. He represents life science companies and academic institutions on intellectual property matters and specializes in the drafting and prosecution of biotechnology and pharmaceutical patent applications. He also carries out due diligence investigations on behalf of operating companies, financial institutions and potential investors.

Areas of Practice
Domaines D’Expertise





Dr. Ashraf has experience in counseling biotechnology, pharmaceutical, diagnostics and medical device companies, research institutions and hospitals on intellectual property matters, with particular emphasis on the procurement and enforcement of patent rights. He specializes in developing and managing domestic and foreign patent portfolios, including developing and implementing complex prosecution strategies in the United States and abroad, and has been involved in post-grant proceedings, including inter partes review and interference proceedings at the United States Patent and Trademark Office, and foreign patent opposition proceedings. Dr. Ashraf has conducted intellectual property due diligence investigations in connection with transactions, including investments in public and privately held companies, public offerings and licensing transactions.

Representative Matters



Patent Portfolio Development and Counseling

Dr. Ashraf has represented life science companies, ranging in size from start-ups to public companies, and academic institutions, including: NovaHep AB (Sweden)*; Chimerix, Inc.*; Acorda Therapeutics, Inc.*; Intarcia Therapeutics, Inc.*; University of Pittsburgh*; Celldex Therapeutics, Inc.*; ForSight Labs.* and Valeant Pharmaceuticals International, Inc.*

* Denotes experience prior to joining Goodwin.

Patent Prosecution
  • Served as an outside patent counsel to Celldex Therapeutics, Inc. and managed four worldwide patent portfolios related to antibody-toxin conjugates for treating cancer*
  • Served as outside patent counsel to NovaHep AB, Sweden and managed three worldwide patent portfolios related to personalized organs for regenerative medicine*
  • Served as outside counsel to University of Pittsburgh’s patent portfolio on muscle-derived stem cells (MDSCs) and managed nine worldwide patent portfolios on tissue and organ regeneration with MDSCs*
  • Managed nine worldwide patent portfolios of Acorda Therapeutics, Inc. relating to neuregulin growth factors for treating nervous and cardiac system diseases and disorders*

* Denotes experience prior to joining Goodwin.

Due Diligence and Transactional Practice
  • Performed IP due diligence in connection with a $35 million public offering*
  • Performed numerous freedom-to-operate searches and patent validity analyses*

* Denotes experience prior to joining Goodwin.

Professional Activities

Dr. Ashraf is a member of a number of professional organizations, including the American Intellectual Property Law Association, the American Bar Association, the Boston Bar Association and the Boston Patent Law Association.

Professional Experience

Prior to joining Goodwin in 2016, Dr. Ashraf was an associate in the Intellectual Property group at Mintz Levin PC (Boston), and, prior to joining Mintz Levin, a Technical Specialist at Sterne, Kessler, Goldstein, & Fox (Washington, D.C.).


Dr. Ashraf has been named as a Massachusetts Rising Star by Super Lawyers in 2015 and 2016.

In The News









J.D., 2013
The George Washington University Law School
M.S., Epidemiology, 2006
Harvard School of Public Health
Ph.D., Cell Biology, 2001
University of Massachusetts Medical School
M.S., Microbiology, 1995
University of Georgia
B.Sc., Biochemistry, 1992
Aligarh Muslim University



U.S. Patent and Trademark Office (USPTO)
Get In Touch
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.


Search Other Lawyers
Recherche par Pratique